Stem Cell Biology & Translational Medicine
OTTED had the first of the “From Discoveries to Commercialization” series, co-sponsored by GE Healthcare Life Sciences on August 5, 2015. The theme was Stem Cell Biology and Translational Medicine. In the morning session, Dr. Hiromitsu Nakauchi, a professor of Stanford University and renowned stem cell biologist, and Dr. Norio Nakatsuji, a professor of Kyoto University and founder of ReproCELL, discussed potential applications of stem cells in medical therapies and commercialization potential of stem cell research. At the afternoon’s tech transfer forum, four University of Hawai`i researchers presented their research and had an open discussion on potential commercialization plans. The event was well received. Any additional feedback can be emailed to otted@hawaii.edu.
 |
 |
 |
 |
 |
 |
 |
 |
 |
<!–
OTTED is hosting a public forum entitled “From Discoveries to Commercialization: Stem Cell Biology & Translational Medicine” on August 5, 2015. The event will showcase UH projects ranging from early stage research to university spinouts. There will be a panel discussion and brainstorming session on technology commercialization plans for the showcased projects.
–>
Panelists
Vernon Oi, Ph.D.
Co-inventor of the process for generating functional antibodies, Stanford’s second highest royalty producer
Norio Nakatsuji, D.Sc.
Professor of Kyoto University and founder of ReproCELL, a leading stem cell company in Japan
Hiromitsu Nakauchi, M.D., Ph.D.
Professor of Stanford and renowned stem cell biologist
Bill Richardson, J.D.
Director of OTTED, seasoned venture capitalist and lecturer at School of Law
UH presenters
Monika Ward, Ph.D.
Institute for Biogenesis Research, JABSOM
Stefan Moisyadi, Ph.D.
Institute for Biogenesis Research, JABSOM
Pietro Bertino, Ph.D.
Cell and Molecular Biology, JABSOM
Aaron Rose, Ph.D.
Cell and Molecular Biology, JABSOM & Bio-Logic Hawaii
<!–